Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
Sampling frame/type of study |
|---|---|
Belgium |
All seizures / routine analysis of seizures. |
Czech Republic |
All seizures / routine analysis of seizures. |
France-A |
All seizures / routine analysis of seizures. |
France-B |
All seizures / routine analysis of seizures. |
Italy |
Analysis of seizures were requested for prosecution/identification purposes. Average potency of cannabis resin is based on seizures of less than 20 grams and of cannabis leaves on seizures of less than 40 grams. |
Latvia |
All seizures / routine analysis of seizures. |
Luxembourg |
All seizures / routine analysis of seizures. |
Hungary |
All seizures / routine analysis of seizures. |
Malta |
All seizures / routine analysis of seizures. |
The Netherlands-A |
User's level: random tests purchases in coffee shops / monitoring system. |
Austria |
All seizures / routine analysis of seizures. |
Poland |
All seizures / routine analysis of seizures. |
Portugal |
All seizures / routine analysis of seizures. |
Slovakia |
Dealer's level and user's level: all seizures / routine analysis of seizures. |
Finland |
All seizures / routine analysis of seizures. |
United Kingdom |
All seizures / routine analysis of seizures. |
Norway |
Analysis takes place only in special circumstances / routine analysis of seizures. |